Molecule Details
InChIKeyUAUIISPUXGSUCV-DMVQEWIISA-N
Compound Namemethyl [(1S)-1-cyclopropyl-2-({(2S,3S,5S)-5-[({[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]oxy}carbonyl)amino]-3-hydroxy-1,6-diphenylhexan-2-yl}amino)-2-oxoethyl]carbamate
Canonical SMILESCOC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)C1CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL9.08
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P04585 gag-pol Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 9.2 Ki BindingDB
Q72874 pol Human immunodeficiency virus type 1 Pathogen PF00077 9.2 Ki ChEMBL
Q9YQ12 protease Human immunodeficiency virus type 1 Pathogen PF00077 8.8 Ki ChEMBL;BindingDB